Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
10 January 2014 09:27
The first once-daily asthma inhaler has been granted approval for use in Britain
The first ever once-a-day asthma inhaler has been approved for use in Britain.
Relvar Ellipta is the name of the new drug, which uniquely combines a steroid dose to reduce inflammation with a new type of long-acting beta2 agonist to open the airways.
Anyone with asthma travel insurance who is planning to book a dream holiday in 2014 may be hopeful that the new medicine could represent a more convenient and effective way to keep their condition under control.
Some people with asthma will even be able to dispense with their blue inhaler, although others will need to continue to also carry one for when they require immediate relief.
Relvar Ellipta has been approved by the European Commission for prescribing by GPs and asthma specialists to adults and adolescents aged 12 and over, though the NHS drug watchdog NICE is yet to evaluate its cost effectiveness.
The new inhaler can also be used by thousands of people living with the lung disease COPD.
Before granting approval, the European Medicines Agency reviewed results from 10 clinical studies involving 7,783 patients with COPD and 16 trials in 9,326 patients with asthma.
Research has revealed that patients use the grey palm-sized device correctly from the outset and up to six weeks later.
The new treatment offers 24-hour help to asthmatics, many of whom are currently failing to keep the condition under control.
Asthma is an inflammatory disease that constricts the airways and the resulting attacks of breathlessness can be fatal.
More than five million Britons are affected by the condition and many of them experience moderate to severe problems.
Up to three out of four of these patients with moderate to severe problems have "uncontrolled" symptoms despite using one inhaler designed to combat an attack and a second inhaler to keep the airways open.
25 April 2018
Hospitals are failing to notice that more than a third of dementia patients suffer from the condition, a new study has found.
[more...]
21 April 2018
Heart attack patients should be prescribed exercise to reduce their risk of death, researchers suggest.
19 April 2018
A self-injected smart drug may be the key to easing and preventing pain for migraine sufferers.
17 April 2018
Simple brain-training exercises carried out at home have been shown to reduce emotional stress in female breast cancer survivors, it's recently been revealed.
13 April 2018
Drinkers who consume more alcohol than UK guidelines suggest could be cutting years off their lives, according to new research.
12 April 2018
A recent study has revealed that people who sustain brain injuries are at an increased risk of developing dementia later in life.
11 April 2018
Scientists have announced their latest breakthrough in the battle against Alzheimer's disease, after neutralising a high-risk gene in a human brain cell for the first time.
07 April 2018
The Philippines is set to shut its most famous holiday island of Boracay for six months, after the President described it as a "cesspool".
05 April 2018
Taxes on soft drinks, alcohol and tobacco - nicknamed "sin taxes" - could be a powerful step towards combating rising rates of chronic diseases worldwide, research has suggested.
New "one-stop shops" to speed up cancer diagnosis are being trialled across the country for the first time.
30 March 2018
Doctors should tell patients that e-cigarettes are less harmful than smoking but not without risk, according to new national guidance.
29 March 2018
Young people suffering from mental health problems are finding it hard to get the support they need, a survey has revealed.